Pfizer SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Nov. 3, 2026, 9:05 a.m. ETView on SEC.gov
10-QNov. 3, 2026, 8:19 a.m. ETView on SEC.gov
8-KNov. 3, 2026, 8:07 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedPfizer Q3 2026 adjusted EPS of $0.87 beats $0.73 consensus on $16.6 billion revenue; full-year adjusted EPS guidance raised to $2.95-$3.05
4Oct. 16, 2026, 6:52 p.m. ETView on SEC.gov
4Oct. 14, 2026, 4:48 p.m. ETView on SEC.gov
4Oct. 1, 2026, 2:04 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:26 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:26 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:25 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:25 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:25 p.m. ETView on SEC.gov
4Sept. 29, 2026, 2:25 p.m. ETView on SEC.gov
4Sept. 16, 2026, 3:17 p.m. ETView on SEC.gov
4Sept. 1, 2026, 5:54 p.m. ETView on SEC.gov
4Aug. 17, 2026, 6:15 p.m. ETView on SEC.gov
4Aug. 12, 2026, 4:04 p.m. ETView on SEC.gov
4Aug. 6, 2026, 11:26 a.m. ETView on SEC.gov
4Aug. 5, 2026, 4:03 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:02 p.m. ETView on SEC.gov
10-QAug. 4, 2026, 7:04 a.m. ETView on SEC.gov
8-KAug. 4, 2026, 7:02 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4Aug. 3, 2026, 7:50 p.m. ETView on SEC.gov